1. Melmed S. Medical progress: acromegaly. N Engl J Med 2006;355:2558-2573.
[CROSSREF] [PUBMED]
2. Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. Eur J Endocrinol 2005;152:379-387.
[CROSSREF] [PUBMED]
3. Swearingen B, Barker FG 2nd, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3419-3426.
[CROSSREF] [PUBMED]
4. Petersenn S, Buchfelder M, Gerbert B, Franz H, Quabbe HJ, Schulte HM, Grussendorf M, Reincke M. Participants of the German Acromegaly Register. Age and sex as predictors of biochemical activity in acromegaly: analysis of 1,485 patients from the German Acromegaly Register. Clin Endocrinol (Oxf) 2009;71:400-405.
[CROSSREF] [PUBMED]
5. Rieger A, Rainov NG, Ebel H, Sanchin L, Shibib K, Helfrich C, Hoffmann O, Burkert W. Factors predicting pituitary adenoma invasiveness in acromegalic patients. Neurosurg Rev 1997;20:182-187.
[CROSSREF] [PUBMED] [PDF]
6. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S5-S20.
[CROSSREF] [PUBMED]
7. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
[CROSSREF] [PUBMED] [PDF]
8. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410.
[CROSSREF] [PUBMED]
9. Etxabe J, Gaztambide S, Latorre P, Vazquez JA. Acromegaly: an epidemiological study. J Endocrinol Invest 1993;16:181-187.
[CROSSREF] [PDF]
11. Mercado M, Espinosa de los Monteros AL, Sosa E, Cheng S, Mendoza V, Hernandez I, Sandoval C, Guinto G, Molina M. Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease. Horm Res 2004;62:293-299.
[CROSSREF] [PUBMED]
12. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004;25:102-152.
[CROSSREF] [PUBMED] [PDF]
13. Choi YJ, Kim HC, Kim HM, Park SW, Kim J, Kim DJ. Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998-2005. Diabetes Care 2009;32:2016-2020.
[CROSSREF] [PUBMED] [PMC]
14. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE. Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 1979;301:1138-1142.
[CROSSREF] [PUBMED]
15. Rodrigues TC, Costenaro F, Fedrizzi D, Oliveira MD, Lima PB, Boschi V, Czepielewski MA. Diabetes mellitus in a cohort of patients with acromegaly. Arq Bras Endocrinol Metabol 2011;55:714-719.
[CROSSREF] [PUBMED] [PDF]
16. Nielsen JH, Galsgaard ED, Moldrup A, Friedrichsen BN, Billestrup N, Hansen JA, Lee YC, Carlsson C. Regulation of beta-cell mass by hormones and growth factors. Diabetes 2001;50(Suppl 1):S25-S29.
[CROSSREF] [PUBMED]
17. Kasayama S, Otsuki M, Takagi M, Saito H, Sumitani S, Kouhara H, Koga M, Saitoh Y, Ohnishi T, Arita N. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin Endocrinol (Oxf) 2000;52:549-555.
[CROSSREF] [PUBMED]
18. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M. Clinical review 75: recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab 1995;80:3395-3402.
[PUBMED]
19. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nat Rev Cancer 2002;2:836-849.
[CROSSREF] [PUBMED] [PDF]
20. Colao A, De Rosa M, Pivonello R, Balestrieri A, Cappabianca P, Di Sarno A, Rochira V, Carani C, Lombardi G. Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly. J Clin Endocrinol Metab 2002;87:4193-4197.
[CROSSREF] [PUBMED]
21. Bates AS, Evans AJ, Jones P, Clayton RN. Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion. Clin Endocrinol (Oxf) 1995;42:417-423.
[CROSSREF]
22. Colao A, Pivonello R, Auriemma RS, Briganti F, Galdiero M, Tortora F, Caranci F, Cirillo S, Lombardi G. Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients. J Clin Endocrinol Metab 2006;91:2112-2118.
[CROSSREF] [PUBMED]